Artelo Biosciences Stock Alpha and Beta Analysis
| ARTL Stock | USD 1.05 0.02 1.94% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Artelo Biosciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Artelo Biosciences over a specified time horizon. Remember, high Artelo Biosciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Artelo Biosciences' market risk premium analysis include:
Beta 1.25 | Alpha (0.37) | Risk 5.06 | Sharpe Ratio (0.04) | Expected Return (0.19) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Artelo |
Artelo Biosciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Artelo Biosciences market risk premium is the additional return an investor will receive from holding Artelo Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Artelo Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Artelo Biosciences' performance over market.| α | -0.37 | β | 1.25 |
Artelo Biosciences expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Artelo Biosciences' Buy-and-hold return. Our buy-and-hold chart shows how Artelo Biosciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Artelo Biosciences Market Price Analysis
Market price analysis indicators help investors to evaluate how Artelo Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Artelo Biosciences shares will generate the highest return on investment. By understating and applying Artelo Biosciences stock market price indicators, traders can identify Artelo Biosciences position entry and exit signals to maximize returns.
Artelo Biosciences Return and Market Media
The median price of Artelo Biosciences for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 is 1.15 with a coefficient of variation of 5.84. The daily time series for the period is distributed with a sample standard deviation of 0.07, arithmetic mean of 1.16, and mean deviation of 0.06. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | ARTL stock touches 52-week low at 1.12 amid market challenges - Investing.com Canada | 09/10/2024 |
2 | Artelo Biosciences, Inc. Short Interest Down 18.3 percent in October | 10/29/2024 |
3 | Artelo Biosciences Reports Third Quarter 2024 Financial Results andProvides Business Update | 11/12/2024 |
4 | Artelo Biosciences Shares Drop Amidst Biotech Sector Movements | 11/27/2024 |
About Artelo Biosciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Artelo or other stocks. Alpha measures the amount that position in Artelo Biosciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2019 | 2020 | 2021 | 2023 (projected) | Net Debt To EBITDA | 0.45 | 0.88 | 0.66 | 0.76 | Intangibles To Total Assets | 0.47 | 0.16 | 0.0998 | 0.11 |
Artelo Biosciences Upcoming Company Events
As portrayed in its financial statements, the presentation of Artelo Biosciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Artelo Biosciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Artelo Biosciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Artelo Biosciences. Please utilize our Beneish M Score to check the likelihood of Artelo Biosciences' management manipulating its earnings.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 29th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Artelo Biosciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Artelo Biosciences Backtesting, Artelo Biosciences Valuation, Artelo Biosciences Correlation, Artelo Biosciences Hype Analysis, Artelo Biosciences Volatility, Artelo Biosciences History and analyze Artelo Biosciences Performance. For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Artelo Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.